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Human oral squamous cell carcinoma (OSCC) is the most frequent malignancy of
the oral cavity. Treatment of OSCC has primarily relied on classical modalities
such as encompassing surgery, radiation, and chemotherapy, or a combination of
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Purpose: Oral squamous carcinoma (OSCC) cells exhibit resistance to chemothe-
rapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels
of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to
apoptosis. Since recent advances in the understanding of bacterial toxins have
produced new strategies for the treatment of cancers, we investigated the effect of
Pseudomonas aeruginosa exotoxin A (PEA) on HSP70 expression and induction
of apoptosis in chemoresistant OSCC cell line (YD-9). Materials and Methods:
The apoptotic effect of PEA on chemoresistant YD-9 cells was confirmed by MTT,
Hoechst and TUNEL stains, DNA electrophoresis, and Western blot analysis.
Results: While YD-9 cells showed high resistance to chemotherapeutic agents such
as etoposide and 5-fluorouraci (5-FU), HSP70 antisense oligonucelotides sensitized
chemoresistant YD-9 cells to etoposide and 5-FU. On the other hand, PEA signifi-
cantly decreased the viability of YD-9 cells by deteriorating the HSP70-relating
protecting system through inhibition of HSP70 expression and inducing apoptosis
in YD-9 cells. Apoptotic manifestations were evidenced by changes in nuclear
morphology, generation of DNA fragmentation, and activation of caspases. While
p53, p21, and E2F-1 were upregulated, cdk2 and cyclin B were downregulated by
PEA treatment, suggesting that PEA caused cell cycle arrest at the G2/M check-
point. Conclusion: Therefore, these results indicate that PEA reduced the chemore-
sistance through inhibition of HSP70 expression and also induced apoptosis in
chemoresistant YD-9 cells.  
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INTRODUCTIONthese methods. However, the five-year survival rate of this
disease has remained in low levels (approximately 50%)
during the past 30 years.
1 In the late stage of malignancy,
neoplastic cells show high resistance to cancer-therapy-
mediated apoptosis.
2,3 Chemoresistance of these cancer
cells is the major impediment to successful chemother-
apies in OSCC. Furthermore, if the OSCCs are removed
surgically, many patients are reported to suffer from facial
distortion. Therefore, inhibition of chemoresistance and
selective removal of OSCC cells could be a promising
strategy for the treatment of OSCC. 
Tumor cells express several proteins that suppress apop-
tosis. Among them, the antiapoptotic members of the Bcl-
2 protein family and members of the inhibitor of apoptosis
protein family have been known to play a major role in
chemoresistance.
4-6 Recently, a group of stress proteins
known as the heat shock proteins (HSP) has been recogni-
zed as a group of apoptosis inhibitors.
7,8 HSP70, especially,
is expressed in response to a wide variety of physiological
and environmental stimulations including anticancer chemo-
therapy, thus allowing the cell to survive lethal conditions.
In cancer cells, the expression of HSP70 is abnormally
high, making the cells resistant to chemotherapy.
8 This is
because HSP70 protects cells from many cell damaging
agents or environmental stressors. Inducible HSP70 is sug-
gested to play multiple roles in cytoprotection against apop-
tosis. One study indicated that HSP70-mediated cytopro-
tection involved the inhibition of caspase activation and
overexpression of HSP70 prevented stress-induced apo-
ptosis by interfering with events both upstream and down-
stream of the stress-activated protein kinase/c-Jun N-termi-
nal kinase signaling pathway, which might be associated
with caspase activation.
9 In addition, 5-fluorouraci (5-FU),
the most commonly used drug in colon cancer therapy, is
reported to induce HSP70 synthesis in a colon cancer cell
line, thereby underlying colon cancer chemoresistance.
10
Therefore, the inhibition of HSP70 has become a novel
strategy of chemoresistant cancer therapy.
Bacterial toxins have emerged as powerful therapeutic
agents with possible applications in treating cancer.
11,12
Several bacterial toxins have been used in the form of an
immunotoxin composed of antibodies linked to bacterial
toxins,
13,14 as well as in purified forms.
15,16 Purified bacterial
toxins such as shiga toxin, cholera toxin, and vacuolating
cytotoxin exhibited apoptosis-inducing activity in cancer
cells.
16,17 Pseudomonas aeruginosa bacterium produces
several extracellular products such as proteases, hemoly-
sins, exotoxin A, exoenzyme S, elastase, and pyocyanin,
18
among which PEA is known to be the most toxic factor
secreted by Pseudomons aeruginosa. PEA enters into
eukaryotic cells via receptor-mediated endocytosis, to be
cleaved in the endocytic vesicles and translocated into the
cytoplasm where it catalyzes the transfer of the ADP-
ribosyl moiety of NAD+ to elongation factor 2 (EF-2).
This inactivation of EF-2 in cells infected with Pseudo-
mons aeruginosa is shown to cause inhibition of protein
synthesis, leading to death of the host cell death.
19 In many
studies undertaken for cancer treatment, PEA has been
employed in the form of immunotoxin.
14,20 PEA-containing
immunotoxin-induced apoptosis in breast cancer cells and
leukemia cells.
21,22 Although PEA-containing immunotoxin
has been studied in various cancer cells, no previous re-
ports have examined the effect of PEA on HSP70 activity
in relation to chemoresistance of cancer cells. Therefore, in
this work, we investigate the effect of PEA on HSP70
expression and chemoresistance of OSC cell line YD-9
cells. Here we demonstrate that PEA decreases the ex-
pression of HSP70, leading to a strong induction of apop-
tosis in chemoresistant YD-9 cells. 
Antibodies
Mouse monoclonal anti-human caspase-6 and Lamin A
antibodies were from Upstate biotechnology (Upstate,
Lake Placid, NY, USA). Mouse monoclonal anti-human
caspase-3, -9 and DFF45, p53, p21, E2F-1, cdk1, cyclin B,
and HSP70 were from Santa Cruz Biotechnology (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA, USA). 
Agents
PEA, dimethyl sulfoxide (DMSO), Hoechst33258, RNase
A, proteinase K, aprotinin, leupeptin, PMSF, and thiazolyl
blue tetrazolium bromide (MTT) were from Sigma Aldrich
(Sigma Aldrich, St. Louis, MO, USA). TUNEL reaction
mixture was from Roche Molecular Biochemicals (Roche
Molecular Biochemicals, Mannheim, Germany). ECL
Western blotting detection reagents were from Amersham
International (Amersham Int., Buckinghamshire, UK).
Cell culture
The YD-9 cell line established from the OSCC patient was
obtained from the Korean Cell Line Bank.
23 The cells were
cultured at 37˚C in a humidified atmosphere containing
5% CO2 in Dulbecco’s modified Eagles medium: Nutrient
Mixture F12 (DMEM/F12, 3 : 1) supplemented with 10%
heat-inactivated fetal bovine serum (FBS), 1% glutamine,
and 100 µg/mL penicillin/streptomycin. 
Cell viability assay
The viability of cultured cells was estimated by an MTT
assay. In the MTT assay, cells were placed in a 96-well
plate and incubated for 24 hours. Then cells were treated
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MATERIALS AND METHODSwith PEA at 0, 1.5, 7.5, 15, 30, and 60 nM for 24 hours.
And then, the cells were treated with 1 mg/mL of MTT in
the growth medium. Cells were incubated at 37˚C for 4
hours. The medium was aspirated and the formazan crys-
tals, which are formed from MTT by NADH-generating
dehydrogenases in metabolically active cells, were dissolv-
ed in 200 mL DMSO. Cell viability was evaluated in com-
parison to the control culture (taken as 100%) by measuring
the intensity of the blue color (OD at 570 nm) by a multi-
well reader (Quant, BioTek, Highland Park, VT, USA).
Four independent experiments were undertaken and each
experiment was conducted in triplicate. 
Identification of proteins using LC-MS/MS
Protein spots of interest were excised and digested in the gel
with a sequencing grade, modified trypsin. The separation
and analysis of tryptic peptides were performed using
reversed phase capillary HPLC directly coupled to a Finni-
gan LCQ ion trap mass spectrometer (LC-MS/MS). Both of
a 0.075×20 mm trapping and a 0.075×130 mm resolving
column were packed in-house with Vydac 218MS low trifl-
uoroactic acid C18 beads (5 µm Vydac, Hesperia, CA, USA)
and placed in-line. Peptides were bound and pre-concen-
trated in the trapping column using 5% (v/v) acetonitrile in
0.1% (v/v) formic acid. The eluting gradient was 5-80%
(v/v) acetonitrile in 0.1% (v/v) formic acid for 50 min at a
flow rate of 0.15 µL/min. Eluent from the capillary column
was directly sprayed into the ion trap mass spectrometer. All
the data were collected in centroid mode using a “triple
play”; a full mass scan at a mass range of 3,952,000 da
(m/z), determination of the ion charge states on zoom scan,
and then an acquisition of MS/MS spectrum of the ion on a
full MS/MS scan, whose collision energy was preset at its
value of 55%. Sequences of uninterpreted MS/MS spectra
were identified by correlating with peptide sequences obtai-
ned from the MSDB, OWL, or NCBI non-redundant protein
database using Mascot software (www.matrixscience.com).
HSP70 antisense oligonucleotide treatment
2×10
5 cells were plated in OptiMEM I medium (Life
Technologies, Inc., Gaitherburg, MD, USA). containing 5
µL of lipofectin (Invitrogen, Life Technologies, Inc., Carls-
bad, California, USA) per mL of OptiMEM I medium per
100 nM oligonucleotide. 500 nM oligonucleotides (5’-
CACCTTGCCGTGCTGGAA-3’) were added to cells and
incubated for 4 hours. Subsequently, the cells were washed
and complete medium was added for 20 hours. The control
sample was incubated for 4 hours in OptiMEM I and lipo-
fectin, but not in oligonucleotides. 
Hoechst staining
Cells treated with PEA for 24 hours and the cell suspension
was centrifuged onto a clean fat-free glass slide with a
cytocentrifuge. The samples were stained 4 µg/mL Hoechst
33258 at 37˚C for 30 min and fixed for 10 min in 4% para-
formaldehyde.
TUNEL assay
To detect breakage of DNA in situ, the TUNEL assay was
conducted with a TUNEL reaction mixture kit (Boehringer
Mannheim, Germany). After PEA treatment, cells were
washed twice with PBS, fixed in 4% paraformaldehyde for
30 min, applied with a permeabilisation solution for 5 min
at 4˚C, and washed again with PBS. This was followed by




6) were resuspended in 1.5 mL of lysis buffer
[10 mM Tris (pH 7.5), 10 mM EDTA (pH 8.0), 10 mM
NaCl and 0.5% SDS] into the added proteinase K (200
µg/mL). After samples were incubated overnight at 48˚C,
200 µL of ice cold 5 M NaCl was added and the super-
natant containing fragmented DNA was collected after
centrifugation. The DNA was then precipitated overnight
at - 20˚C in 50% isopropanol and RNase A-treated for 1
hour at 37˚C. A loading buffer containing 100 mM EDTA,
0.5% SDS, 40% sucrose, and 0.05% bromophenol blue
were added at 1 : 5 (v/v). Separation was achieved in 2%
agarose gels in Tris-acetic acid/EDTA buffer (containing
0.5 µg/mL ethidium bromide) using 50 mA for 1.5 hour. 
Western blot analysis
Cells (2×10
6) treated with PEA were washed twice with
ice-cold PBS, resuspended in a 200 µL ice-cold solu-
bilizing buffer [300 mM NaCl, 50 mM Tris-Cl (pH 7.6),
0.5% TritonX-100, 2 mM PMSF, 2 µL/mL aprotinin and 2
µL/mL leupeptin], and incubated at 4˚C for 30 min. The
lysates were centrifuged at 14,000 revolutions per min for
15 min at 4˚C. Protein concentrations of cell lysates were
determined with a Bradford protein assay (BioRad, Rich-
mond, CA, USA) and 50 µg of proteins were loaded onto
7.5-15% SDS/PAGE. The gels were transferred to the
Nitrocellulose membrane and reacted with each antibody.
Immunostaining with antibodies was performed using
SuperSignal West Pico enhanced chemiluminescence sub-
strate and detected with LAS-3000PLUS (Fuji Photo Film
Company, Kanagawa, Japan). 
PEA reduced the viability of YD-9 cells
To investigate if PEA has a cytotoxic effect on YD-9 cells,
Sang Rye Park, et al.
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RESULTSan MTT assay was conducted. Viability of YD-9 cells did
not significantly decrease after treatment with etoposide
(2-10 µg/mL) and 5-FU (1-2,000 µM) at concentrations
shown where many cancer cells are responsive. Further-
more, the proliferation of YD-9 cells was rarely affected
by various concentrations of another antitumor agent geni-
stein (data not shown). However, PEA at concentrations
raging from 1.5 to 60 nM substantially reduced the viability
of YD-9 cells (Fig. 1). 
PEA decreased HSP70 expression 
In an attempt to identify changes of protein expression by
PEA treatment, identification of proteins using LC-MS/MS
was performed. Among many differentially expressed
proteins, HSP70 was identified and exhibited a significant
decrease in response to PEA treatment (Fig. 2A). The level
of HSP70 expression was compared by Western blotting
on YD-9 and human normal gingival fibroblast (HGF-1).
The result illustrated in Fig. 2B showed an increase in
HSP70 expression in YD-9 cells. Densiometric analysis
indicated that HSP70 expression was five times higher in
YD-9 compared to what is obtained from HGF-1. Overex-
pression of HSP70 decreased in various concentrations of
PEA after 24 hours incubation (Fig. 2C) and at various
time points after incubation with 15 nM PEA (Fig. 2D). 
Inhibition of HSP70 by PEA decreased resistance to
etoposide and 5-FU
To examine if HSP70 plays any role in chemoresistance of
YD-9 cells to anti-cancer drugs such as etoposide and 5-
FU, HSP70 antisense oligonucleotide was administered to
YD-9 cells. The treatment of HSP70 antisense oligonu-
cleotide significantly increased the sensitivity of the cells
to these anti-cancer drugs compared to anti-cancer drug
treatment alone (Fig. 3A). We further confirmed the inhibi-
tory effect of PEA on chemoresistance of YD-9 cells to
etoposide and 5-FU. The treatment of YD-9 cells with
etoposide and 5-FU, following incubation in 1.5 nM PEA for
24 hours, significantly decreased the viability of YD-9 cells
compared to anti-cancer drug treatment alone (Fig. 3B). 
Reduced viability of YD-9 cells was resulted from PEA
induced apoptosis
We examined whether the reduced viability of YD-9 cells
was caused by apoptosis. Hoechst staining showed nuclear
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Fig. 1. Effects of PEA treatment on the viability of chemoresistant YD-9 cells. (A) After 24 h incubation with etoposide (2 - 10 µg/mL) and (B) 5-FU (1 - 2,000 µM), cell
viabilities were determined by MTT assay. YD-9 cell line showed resistance to etoposide and 5-FU, (C) whereas PEA significantly decreased the proliferation of YD-9
cells. Four independent assays were performed and data shown are the mean  ±SD of the means obtained from triplicates of each assay.
Fig. 2. Detection of HSP70 and the effect of PEA on HSP70 expression in YD-9
cells. (A) After incubation with15 nM PEA for indicated periods, identification of
differentially expressed proteins using LC-MS/MS indicated HSP70. (B)
Western blot for HSP70 from YD-9 and HGF-1 cells was performed. The
expression level of HSP70 in YD-9 cells was higher than HGF-1 cells. (C) After
incubation with indicated doses of PEA for 24 hours, Western blot analysis
showed a decrease of HSP70 expression. (D) After incubation with 15 nM of
PEA for indicated time periods, Western blot analysis showed a time-
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Dcondensation and fragmentation in YD-9 cells after 24
hours treatment of 15 nM PEA (Fig. 4A). In the TUNEL
assay, a large number of cells treated with 15 nM PEA for
24 hours exhibited a positive response (Fig. 4B). Cells
treated with 15 nM PEA showed DNA degradation chara-
cteristics of an apoptotic ladder (Fig. 4C). To examine if
the apoptosis was mediated by caspases, we carried out
Western blotting experiments which indicated that PEA
activated two effectors, caspases caspase-3 and -6. In addi-
tion to the degradation of caspase-3 and -6, cleaved products
of each caspase were obtained (Fig. 5A). In the experiment
to study the effects of PEA on caspase target proteins such
as DFF45 and lamin A, the cleaved products of DFF45 (30
and 11 kDa) and lamin A (45 and 28 kDa) were observed
(Fig. 5B).
Cell cycle protein E2F-1 was involved in PEA induced-
apoptosis
The transcription factor E2F-1 plays a role in apoptosis as
well as cell cycle progression and enhances the expression
Sang Rye Park, et al.
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Fig. 3.Restoration of sensitivity to etoposide and 5-FU by inhibition of HSP70. (A) After incubation with HSP70 antisense oligonucleotide for 24 hours
as described in the material and methods section, YD-9 cells were treated with various concentrations of etoposide and 5-FU. (B) After incubation
with 15 nM PEA for 24 hours, YD-9 cells were treated with various concentrations of etoposide and 5-FU. Cell viabilities were determined by an
MTT assay. Four independent assays were performed and data shown are the mean ±SD of the means obtained from triplicates of each assay.
Fig. 4. Demonstration of apoptosis in YD-9 cells treated with 15 nM PEA. (A) Nuclear condensation and fragmentation were clearly shown at 24
hours after treatment with 15 nM PEA. (B) A TUNEL assay showed apoptotic cells in YD-9 cells treated with PEA. (C) DNA electrophoresis showed
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Ctrl PEAof Apaf-1. Therefore, the changes in the expression of E2F-
1, Apaf-1, and caspase-9 were investigated in YD-9 cells.
As shown in Fig. 6, E2F-1 expression levels were markedly
increased at 16 and 24 hours after PEA treatment and
decreased thereafter. The expression of Apaf-1 increased
at 16 and 24 hours after PEA treatment. These observa-
tions were accompanied by initial caspase-9 cleavage at 16
hours, with cleaved protein, reaching a peak concentration
between 16 and 48 hours (Fig. 6). 
PEA treatment induced cell cycle arrest at G2/M 
checkpoint
We then investigated if PEA could modulate cell cycle
regulatory proteins. We examined changes in protein levels
using antibodies against key players in G2/M cell cycle
regulation. Western blot analysis demonstrated that p53
increased at 8 and 16 hours after incubation with PEA, and
then decreased. The expression of p21 increased after
incubation with PEA, whereas the expression of cdk1 and
cyclin B decreased in a time-dependent manner (Fig. 7). 
Chemoresistant tumor cells have acquired the ability to
evade the action of multiple classes of anti-cancer drugs.
One mechanism by which tumor cells survive in the pre-
sence of chemotherapy is the increase of anti-apoptotic
activities. Because resistance to chemotherapy is a major
failure in the treatment of OSCC, there is great interest in
the search for new compounds that may destroy OSCC
cells, which eventually can be incorporated into therapy
for the treatment of OSCC. We have shown here that the
purified form of PEA has a strong cytotoxic effect on
chemoresistant YD-9 OSC cells through the induction of
apoptosis.
Etoposide and 5-FU are known to inhibit the prolifera-
tion of various cancer cells.
10,24 In particular, 5-FU has been
Inhibition of HSP70 by PEA 
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DISCUSSION
Fig. 6. Involvement of E2F-1, Apaf-1, and caspase-9 in PEA-induced apoptosis.
YD-9 cells were cultured in the presence of 15 nM PEA for the indicated time,
and whole cell lysates were subjected to Western blot analysis of E2F-1 (56
kDa), Apaf-1 (130 kDa), and caspase-9 (full-length, 49 kDa; cleaved, 37 kDa). 
Fig. 7. Western blot analysis of cell cycle regulation proteins in YD-9 cells
treated with 15 nM PEA. YD-9 cells were treated with 15 nM PEA for the
indicated time. Total cellular lysate proteins were resolved by SDS-PASE,
transferred to nitrocellulose membranes, and probed for p53, p21, cdk1, and
cyclin B. 
Fig. 5. Demonstration of PEA induced the cleavage of caspase-3, capase-6, DFF45, and lamin A. (A) Pro-form of caspase-3 (32 kDa) was degraded,
and 17 kDa and 12 kDa cleaved forms were produced after PEA treatment. Caspase-6 pro-enzyme (34 kDa) was degraded, and 16 kDa cleaved
forms were produced after PEA treatment. (B) Three cleaved products of DFF45 (30, 20, and 11 kDa) were demonstrated in YD-9 cells treated with
PEA, which are evident in later time points (48 and 72 hours). Two cleaved products of lamin A (45 and 28 kDa) are demonstrated in YD-9 cells
treated with PEA, which are shown at 24 hours after PEA treatment.
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37 kDawidely used in the treatment of OSCC and is reported to
induce apoptosis in OSC cells.
25,26 However, etoposide and
5-FU at usual doses did not substantially inhibit the proli-
feration of YD-9 cells in this study. These results demons-
trate that YD-9 cells are resistant to etoposide and 5-FU.
Previous studies elucidated that PEA induces cellular death
via apoptosis in normal cells including mouse hepatocyte
27
and human mast cells.
28 Because of its apoptosis-inducing
activity, PEA in the form of immunotoxin has been widely
used to kill target cells. However, very little is known about
the effect of PEA on the chemoresistance of cancer. In this
study, PEA at nanomolar concentrations strongly inhibited
the growth of YD-9 cells dose-dependently, suggesting
that PEA has a strong cytotoxic effect on chemoresistant
cancer cells. 
HSP70 is overexpressed in many cancer cells and is
involved in antiapoptotic pathways by the inhibition of
apoptotic signals.
8,9 It was reported that the overexpression
of HSP70 in U937 lymphoma cells clearly prevented
caspase-3 activation, poly (ADP-ribose) polymerase clea-
vage, and DNA laddering.
29 These antiapoptotic roles
suggest that HSP70 may be involved in resistance to chemo-
therapeutic agents. In this study, HSP70 was weakly ex-
pressed in normal HGF-1 cells, whereas it was detected at
a five-fold increase in chemoresistant YD-9 cells. PEA
decreased highly expressed HSP70 in a dose- and time-
dependent manner in these cells. To determine whether the
decrease of HSP70 is related to resistance of YD-9 cells to
5-Fu and etoposide, we blocked HSP70 expression with
HSP70 antisense oligonucleotides. We then observed that
5-FU or etoposide treatment significantly inhibited the
proliferation of chemoresistant YD-9 cells at a low dose.
Furthermore, after the low dose of PEA treatment, 5-FU or
etoposide also significantly decreased the viability of YD-
9 cells. These results suggest that PEA works through a
HSP70-dependent mechanism, so that chemoresistant YD-
9 cells become sensitive to anticancer drugs. Moreover,
these findings are in agreement with a study showing that
prolonged downregulation of HSP72 lead to severe sup-
pression of the major survival pathways which may be
responsible for enhanced sensitivity of prostate carcinoma
cells to a variety of anticancer treatments.
30
Recent studies have suggested that many therapeutic
agents used against cancer, such as immunotherapy, chemo-
therapy, and irradiation, mediate their effects by induction
of apoptosis of the cancer cells.
31,32 Apoptosis is a regulated
cell death process induced by signaling from diverse stimuli
through specific cell surface receptors which trigger a
cascade of intracellular molecules that initiate the cell death
program.
33,34 Caspases play an important role in the execu-
tion phase of apoptosis and are responsible for many of the
biochemical and morphological changes associated with
apoptosis.
35 Caspases are known to cleave a number of
proteins and the consequences of these cleavage events
were suggested to be responsible for many of the pheno-
typic changes in the cell undergoing apoptosis.
36,37 PEA-
containing immunotoxin induced a loss of mitochondrial
membrane potential and activation of the caspase cascade
in MA-11 breast cancer cells.
21 Here, the growth inhibitory
effect of the PEA was demonstrated to be derived from
induction of apoptosis. We presented the nuclear conden-
sation in PEA-induced apoptosis by Hoechst staining. PEA
treatment induced caspase-3 and -6 cleavages, and activa-
tion evidently resulted in cleavages of substrates such as
DNA fragmentation factor 45 (DFF45) and lamin A. 
E2F is a family of transcription factors that control G1/S
transition of eukaryotic cells by regulating the expression
of a large spectrum of genes required for DNA synthesis.
38
Among E2F family members, E2F-1 has been shown to
participate in apoptotic pathways by stimulating the accu-
mulation of caspases through a direct transcriptional mecha-
nism.
39,40 The apoptosis-inducing ability of E2F-1 plays an
important role in suppressing the expansion of proliferat-
ing cells, and thus provides a cancer-defense mechanism.
Deregulation of E2F-1 activity contributes to enhanced
proliferation and resistance to cytotoxic drugs in human
melanoma cells.
41 E2F-1 has been reported to activate cas-
pase-9 in order to initiate the caspase cascade without mito-
chondrial damage; this activity of caspase-9 was caused by
the up-regulation of Apaf-1.
42,43 Furthermore, due to its
contribution in selective killing of cancer cells by beta-
lapachone,
44 E2F-1 has been an attractive target as a new
type of cancer therapeutics. In this study, increased protein
levels of E2F-1 and Apaf-1 were observed at 16 and 24
hours after PEA treatment in YD-9 cells. Initial caspase-9
was cleaved at 16 hours after PEA treatment, suggesting
that caspase-9 may be activated by the increase of Apaf-1
and E2F-1. We propose that PEA causes the activation of
E2F-1 to provide a potent apoptotic signal in YD-9 cells.   
Usually, p53 acts as an “emergency break” inducing
either cell cycle arrest or apoptosis, protecting the genome
from accumulating excess mutations. In response to sti-
muli, p53 is stabilized and activated by multiple mecha-
nisms (including phosphorylation, dephosphorylation, and
acetylation). Once activated, p53 either induces cell-cycle
arrest at G1 or G2 by increasing the transcription of the p21
gene or initiate apoptosis.
45 Several transcriptional targets
of p53 including p21 can inhibit cdk1, thereby deficiency
of activated cyclin B-cdk1 induces cell cycle arrest at the
G2/M checkpoint. This study demonstrated that PEA
treatment upregulated p53 and p21, and downregulated
cdc2 and cyclin B, which suggests that PEA induces cell
cycle arrest at the G2/M checkpoint and subsequent pro-
gress to apoptosis. 
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tective system and thereby causes YD-9 cells to lose resis-
tance to anti-cancer drugs. Furthermore, PEA has a strong
apoptotic effect on chemoresistant YD-9 cells via the acti-
vation of caspases and the regulation of cell cycle genes.
Therefore, an inhibitory effect of HSP70 and apoptotic
effect of PEA suggests a potential use of this compound in
the chemoresistant oral cancer cells.
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